Regeneron Pharmaceuticals
(NASDAQ: REGN)
231.38
-11.38-4.69%Today's Close
|
231.38
unch
After hours
-11.38-4.69%Today's Close
|
231.38
unch
After hours
MORE ON REGN
| 2012 | 2011 | 2010 | 2009 | 2008 | |
| Period End Date | 12/31/2012 | 12/31/2011 | 12/31/2010 | 12/31/2009 | 12/31/2008 |
| Stmt Source | N/A | N/A | N/A | N/A | N/A |
| Stmt Source Date | 12/31/2012 | 02/15/2013 | 02/15/2013 | 02/17/2011 | 02/18/2010 |
| Stmt Update Type | Original | Updated | Updated | Updated | Updated |
| Currency Code | USD | USD | USD | USD | USD |
Net Income
|
750.3 | -221.8 | -104.5 | -67.8 | -79.1 |
| Net Income from Continuing Operations | 750.3 | -221.8 | -104.5 | 0.0 | 0.0 |
|
Operating Gains/Losses
|
0.0 | 0.0 | 0.0 | -0.1 | 2.2 |
| Gain/Loss on Investment Securities | 0.0 | 0.0 | 0.0 | -0.1 | 1.3 |
| Depreciation,Amortization and Depletion | 36.9 | 31.1 | 19.7 | 14.2 | 11.3 |
| Deferred Taxes | -340.2 | 0.0 | 0.0 | 0.0 | 0.0 |
|
Other Non-Cash Items
|
151.1 | 67.4 | 44.0 | 31.3 | 32.5 |
| Stock-Based Compensation | 94.2 | 56.1 | 39.9 | 31.3 | 32.5 |
| Change in Receivables | -590.1 | -21.1 | -17.5 | -30.4 | -16.9 |
| Change in Prepaid Assets | -52.6 | -7.0 | -8.2 | -4.6 | -6.6 |
|
Change in Pay/Accrued Exp
|
11.0 | 50.0 | 7.6 | 12.6 | -5.7 |
|
Change in Payables
|
11.0 | 50.0 | 7.6 | 0.0 | -5.7 |
| Change In Account Payable | 0.0 | 0.0 | 0.0 | 0.0 | -5.7 |
| Change in Other Working Capital | -41.1 | -40.3 | 158.2 | -27.5 | -26.8 |
| Cash Flow from Operating Activities | -74.6 | -141.7 | 99.2 | -72.2 | -89.1 |
|
Purchase/Sale of Investments,Net
|
-31.2 | 186.0 | -331.4 | 97.4 | 65.7 |
|
Purchase of Investments
|
-470.4 | -240.4 | -605.1 | -200.0 | -581.1 |
| Purchase of Short Term Investments | -470.4 | -240.4 | -605.1 | -200.0 | -581.1 |
|
Sale of Investments
|
439.2 | 426.4 | 273.7 | 297.4 | 646.9 |
| Sale of Short Term Investments | 439.2 | 426.4 | 273.7 | 297.4 | 646.9 |
| Other Investing Changes,Net | -0.6 | -0.3 | -5.9 | 0.1 | -0.1 |
| Cash Flow from Investing Activities | -81.1 | 128.5 | -437.0 | 0.1 | 30.8 |
|
Issuance/Payments of Debt,Net
|
-2.2 | 389.4 | 46.5 | 22.8 | -200.8 |
|
Issuance/Payments of LT Debt,Net
|
-2.2 | 389.4 | 46.5 | 22.8 | -200.8 |
| Payments to Settle Long Term Debt | -2.2 | -1.7 | -1.0 | -0.9 | -200.8 |
| Proceeds or Issuance of Long Term Debt | 0.0 | 391.1 | 47.5 | 23.6 | 0.0 |
|
Issuance/Payments of Common Stock,Net
|
-99.8 | 112.3 | 196.8 | 8.6 | 7.9 |
| Payments for Common Stock | -163.3 | -25.1 | -3.8 | 0.0 | 0.0 |
| Proceeds or Issuance of Common Stock | 63.5 | 137.4 | 200.6 | 8.6 | 7.9 |
| Other Financing Changes, Net | 4.3 | -117.5 | 0.0 | 0.0 | 0.0 |
| Cash Flow from Financing Activities | -97.6 | 384.2 | 243.3 | 31.4 | -192.9 |
| Cash, Equivalents, Start of Period | 483.6 | 112.6 | 207.1 | 247.8 | 498.9 |
| Cash, Equivalents, End of Period | 230.3 | 483.6 | 112.6 | 207.1 | 247.8 |
| Change in Cash | -253.3 | 371.0 | -94.5 | -40.7 | -251.1 |
| Free Cash Flow | -124.0 | -198.9 | -0.5 | -169.5 | -123.9 |
DATA PROVIDERS
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.